跳至主要内容
临床试验/NCT01633658
NCT01633658撤回不适用

The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3 Compared to Native Vitamin D3: A Short Term Pharmacokinetic Study

Creighton University1 个研究点 分布在 1 个国家开始时间: 2012年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Serum 25(OH)D response

研究概览

简要总结

The investigators hypothesize that native vitamin D will have more variability in 25(OH)D dose response when compared to a given equipotent dose of 25-hydroxyvitamin D3. This will be a single blind, active control, pharmacokinetic study of 625 μg 25(OH)D given orally or 2500 μg native vitamin D given orally.

详细描述

Single blind, active control, pharmacokinetic study of 625 μg 25(OH)D given orally or 2500 μg native vitamin D given orally.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Ten men and women in each group,
  • •aged 20-60.

排除标准

  • •History of hypercalcemia,
  • •vitamin D supplement use > 800 IU daily,
  • •BMI > 30,
  • •gastrointestinal malabsorption (from celiac sprue, colitis, surgery, etc.), kidney disease or liver disease,
  • •use of steroids in any form,
  • •anticonvulsants,
  • •antibiotics,
  • •acute illness, or
  • •vacation planned to "sunny climate"

研究组 & 干预措施

25(OH)D

Experimental

A single dose of 625 micrograms 25(OH)D

干预措施: 25(OH)D (Dietary Supplement)

Vitamin D Cholecalciferol

Active Comparator

A single dose of 2500 micrograms cholecalciferol

干预措施: cholecalciferol (Dietary Supplement)

结局指标

主要结局

Serum 25(OH)D response

时间窗: 28 days

25(OH)D will be measured at frequent time intervals over 28 days.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验